Invesco Pharmaceuticals ETF
PJP
97 hedge funds and large institutions have $66M invested in Invesco Pharmaceuticals ETF in 2024 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 20 increasing their positions, 29 reducing their positions, and 3 closing their positions.
300% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 3
9% more funds holding
Funds holding: 89 → 97 (+8)
4% more capital invested
Capital invested by funds: $63.6M → $66M (+$2.39M)
0.13% less ownership
Funds ownership: 23.13% → 23% (-0.13%)
31% less repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 29
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
+$1.14M |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$960K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$561K |
| 4 |
HAS
HBW Advisory Services
Simi Valley,
California
|
+$501K |
| 5 |
AWA
Arete Wealth Advisors
Chicago,
Illinois
|
+$395K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DBIA
Dumont & Blake Investment Advisors
Princeton,
New Jersey
|
-$1.71M |
| 2 |
Morgan Stanley
New York
|
-$1.03M |
| 3 |
Goldman Sachs
New York
|
-$701K |
| 4 |
Focus Partners Wealth
Boston,
Massachusetts
|
-$506K |
| 5 |
QAM
Q3 Asset Management
Birmingham,
Michigan
|
-$390K |
PJP Hedge Fund Activity: Q3 2024 in Review
97 of the 6,978 institutional investors tracked by Wall St. Rank reported a position in Invesco Pharmaceuticals ETF (PJP) for Q3 2024, worth a combined $66M — up 3.8% from $63.6M a quarter earlier.
Buyers outnumbered sellers: 12 funds opened new PJP positions and 3 closed out — a net gain of 9 holders — while 20 added to existing stakes and 29 trimmed.
The largest buyer was Jane Street, opening a new position worth an estimated $1.14M. The largest seller was Dumont & Blake Investment Advisors, cutting an estimated $1.71M.
- 97 institutional investors held Invesco Pharmaceuticals ETF (PJP) as of Q3 2024, up from 89 in Q2 2024.
- Funds reported $66M of Invesco Pharmaceuticals ETF stock for Q3 2024, up 3.8% quarter-over-quarter.
- 12 funds opened new Invesco Pharmaceuticals ETF positions in Q3 2024 and 3 closed out, a net change of +9 holders.
- The largest Invesco Pharmaceuticals ETF buyer in Q3 2024 was Jane Street, an estimated $1.14M added.
- The largest Invesco Pharmaceuticals ETF seller in Q3 2024 was Dumont & Blake Investment Advisors, an estimated $1.71M sold.
Based on aggregated 13F filings for Q3 2024.